SCHEMBL31350867

SCHEMBL31350867

CCOC(=O)c1c(OC)cc(C)nc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.47
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HPGD P15428 4/20 0.47
MAPT P10636 4/20 0.47
KDM4E B2RXH2 4/20 0.47
TP53 P04637 2/20 0.47
HSD17B10 Q99714 2/20 0.47
RAB9A P51151 1/20 0.47
LMNA P02545 1/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.44
MAPK10 P53779 1/20 0.44
FHIT P49789 1/20 0.44
POLB P06746 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B2 P37059 1/20 0.43
CYP3A4 P08684 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11808110 0.83 KDM4E (0.52) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL1628027 0.82 ALDH1A1 (0.47) GAAALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL9271057 0.81 KMT2A (0.51) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL17343185 0.76 GAA (0.43) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL16684814 0.76 ALDH1A1 (0.47) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL11809086 0.74 KDM4E (0.46) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL13554532 0.74 CYP3A4 (0.63) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL3191583 0.73 SMN1; SMN2 (0.61) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL11853743 0.73 MAPK1 (0.54) GAAALDH1A1SMN1; SMN2HPGDMAPT
SCHEMBL24772939 0.73 GAA (0.53) GAAALDH1A1SMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743462-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2026-05-20 EP disclosed
WO-2025012643-A1 COMPOUNDS COMPRISING A NAPHTHYRIDINE OR PYRIDOPYRIMIDINE CORE AS PTC READ-THROUGH AGENTS Tay Therapeutics Limited (GB) 2025-01-16 WO disclosed